Respiratory Viral Panel by PCR
Also known as: RVPPCR
Use
The Respiratory Viral Panel by PCR is the preferred test for evaluating severely immunocompromised (e.g., bone marrow transplant patients) or critically ill patients in the ICU with respiratory symptoms. It detects a wide range of respiratory viruses including influenza (A and B), RSV, parainfluenza (types 1, 2, 3, and 4), human metapneumovirus, human rhinovirus, and adenovirus, helping guide appropriate management and treatment decisions.
Special Instructions
Nasopharyngeal swab specimens must be placed in viral transport media and each specimen should be in an individually sealed bag available through ARUP eSupply or Client Services.
Limitations
A negative result does not rule out the presence of PCR inhibitors in the patient specimen. Furthermore, the assay may not detect nucleic acids of the targeted viruses present at concentrations below the limit of detection. Therefore, clinical correlation with patient history and other diagnostic information is essential.
New York Approved
Methodology
PCR-based (qPCR)
Biomarkers
LOINC Codes
- 31208-2
- 34487-9
- 40982-1
- 29908-1
- 29909-9
- 29910-7
- 38917-1
- 7993-9
- 40988-8
- 41010-0
- 39528-5
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Nasopharyngeal Swab
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Place nasopharyngeal swab in viral transport media. Contact ARUP Client Services or use eSupply for obtaining media.
Causes for Rejection
Specimens not in viral transport media.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 4 days |
| Frozen | 1 month |